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Abstract
Increased deposition of amyloid-b peptide (Ab) at the cerebral endothelial cell (CEC) surface has been implicated in
enhancement of transmigration of monocytes across the brain blood barrier (BBB) in Alzheimer’s disease (AD). In this study,
quantitative immunofluorescence microscopy (QIM) and atomic force microscopy (AFM) with cantilevers biofunctionalized
by sialyl-Lewisx (sLex) were employed to investigate Ab-altered mechanics of membrane tethers formed by bonding
between sLex and p-selectin at the CEC surface, the initial mechanical step governing the transmigration of monocytes. QIM
results indicated the ability for Ab to increase p-selectin expression at the cell surface and promote actin polymerization in
both bEND3 cells (immortalized mouse CECs) and human primary CECs. AFM data also showed the ability for Ab to increase
cell stiffness and adhesion probability in bEND3 cells. On the contrary, Ab lowered the overall force of membrane tether
formation (Fmtf), and produced a bimodal population of Fmtf, suggesting subcellular mechanical alterations in membrane
tethering. The lower Fmtf population was similar to the results obtained from cells treated with an F-actin-disrupting drug,
latrunculin A. Indeed, AFM results also showed that both Ab and latrunculin A decreased membrane stiffness, suggesting a
lower membrane-cytoskeleton adhesion, a factor resulting in lower Fmtf. In addition, these cerebral endothelial alterations
induced by Ab were abrogated by lovastatin, consistent with its anti-inflammatory effects. In sum, these results
demonstrated the ability for Ab to enhance p-selectin expression at the CEC surface and induce cytoskeleton
reorganization, which in turn, resulted in changes in membrane-cytoskeleton adhesion and membrane tethering,
mechanical factors important in transmigration of monocytes through the BBB.
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Introduction
Alzheimer’s disease (AD) is the most prevalent age-related
neurodegenerative disease affecting higher cognitive functions,
learning, and memory of millions people worldwide. It is the most
common cause of dementia and the sixth-leading cause of death
among people aged 65 and older. Increased deposition of amyloid
b peptide (Ab) together with the increased numbers of activated
microglial cells in the parenchyma, and monocytes in the vessel
wall of AD brain have been observed [1,2]. Recent epidemiolog-
ical and laboratory studies have indicated the important role of
cerebral vascular factors in the progression of AD [3,4]. Peripheral
monocytes have been shown to migrate across the blood-brain
barrier (BBB) and differentiate into microglia within the brain
parenchyma [5]. In vitro studies have provided evidence demon-
strating that Ab deposition at the endothelial cell layer enhances
the transmigration of monocytes [6–8]. Increased transmigration
of monocytes into brains is thought to drive the disease progression
towards exacerbation of the oxidative and inflammatory condi-
tions characteristic of the AD brain.
Transmigration of monocytes is a sequential process with three
distinct adhesive events: 1) capture, tethering and rolling; 2) firm
adhesion and arrest; and 3) crawling on the endothelial surface to
find an intercellular junction for transmigration to the target tissue.
Primary capture by the endothelium and rolling are mediated by
tethering to selectins and selectin ligands [9,10]. Selectins belong
to the type I transmembrane cell adhesion molecule family and are
comprised of three members, namely, P, E, and L-selectins. P-and
E-selectin are expressed on the endothelial cell surface upon
exposure to different pro-inflammatory agents such as TNF-a,
interleukin, and lipopolysaccharide. Their roles in immune cell
rolling vary depending on the particular stimuli and the type of
tissue. The physiological ligands for selectins are glycoproteins,
including P-selectin glycoprotein ligand 1(PSGL-1), E-selectin
ligand 1 (ESL-1), and CD34. All these ligands carry conjugated
carbohydrate sialyl Lewisx (sLex) as an active binding site [11,12].
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It is also important to note that cell-cell adhesion is governed by
the expression of adhesion molecules and their ligands as well as
the mechanical properties of the cells and cell membranes [13–
15]. Since the transmigration of monocytes across the BBB is both
a mechanical and biochemical process, the expression of adhesion
molecules and mechanical properties of endothelial cells are
critical factors that require investigation. In this study, we applied
AFM with cantilever tips bio-functionalized by sLex (Fig. 1) in
combination with quantitative immunofluorescence microscopy
(QIM) to study the direct effects of Ab oligomers on selectin
expression, actin polymerization, and mechanical and adhesion
properties in cerebral endothelial cells. In addition, we examined if
lovastatin, a cholesterol-lowering drug, attenuates Ab effects.
Materials and Methods
Reagents
Ab1–42 from American Peptides were prepared by diluting
5 mM Ab1–42 in DMSO to 100 mM in ice-cold culture Ham’s
medium and incubating at 4uC for 24 h. Lovastatin (Calbiochem)
was prepared following the manufacturer’s instruction. Briefly,
Lovastatin was converted into its active form by dissolving it in
absolute ethanol (20 mg/ml lovastatin) followed by the addition of
1N NaOH (to final concentration of 0.45 M). This solution could
be stored at 220uC until used. The solution was neutralized
(pH 7.2) with 1 N HCl immediately prior to the use. Latrunculin
A (Sigma) was dissolved in DMSO and then diluted in cell culture
medium to final concentration of 1 mM.
Cell culture
Mouse immortalized cerebral endothelial cells (bEnd3 line) were
from ATCC (Manassas, VA, USA), and primary human cerebral
endothelial cells (CEC) were from ScienCell Research Laborato-
ries (Carlsbad, CA, USA). Cells were cultured in DMEM with
10% PBS and 1% antibiotic/antimycotic and maintained in
humidified 5% CO2 incubator at 37uC.
Cell treatments
To demonstrate the effects of Ab oligomers on CECs, cells were
treated with two different concentrations of Ab oligomers (0.5 mM
and 1 mM) for 20 min prior to further characterizations. To test if
statin was capable of counteracting the effects of Ab, cells were
pre-treated with Lovastatin (20 mM) for 1 h, followed by Ab
treatment (1 mM). For a positive control of inflammatory
responses, CECs were treated with histamine (10 mM for
20 min). To demonstrate the role of cytoskeletal organization,
cells were incubated with 1 mM Latrunculin A (an actin
polymerization inhibitor) for 30 min before characterizations.
Immunofluorescent labeling
Cells were grown on cover slips until confluent. After
treatments, cells were fixed immediately using 3.7% paraformal-
dehyde solution for 30 min. To block non-specific binding, 5%
BSA in PBS was applied to cells for 1 h. P- or E-selectins at the cell
surface were labeled with its primary antibody (R&D systems)
without permeabilization at 4uC overnight, followed by goat Alexa
Fluor 594 anti-rat secondary antibody (Invitrogen) at 25uC for 1 h.
To confirm the specificity of the selectin primary antibodies,
labeling by secondary antibodies alone did not show immuno-
staining in the absence of the primary antibody. For F-actin
labeling, cells were permeablized by 0.1% Triton X-100 in PBS
for 5 min and incubated with Oregon-green phalloidin (250 nM)
(Invitrogen) in PBS with 1% BSA at 25uC for 1 h.
Quantitative Immunofluorescence microscopy (QIM)
Bright-field illumination and fluorescence microscopy were
performed with Nikon TE-2000 U fluorescence microscope and
406, NA 0.95 objective. Images were acquired using a cooled-
CCD camera controlled with a computer that runs MetaView
imaging software. The typical exposure time for fluorescence
image acquisition was 400 msec. Background subtraction was
performed for all images prior to analysis. Actin polymerization
was quantified by calculating the intensity of Oregon Green-
phalloidin-labeled F-actin per cell area. The intensity was then
normalized by the intensity of the labeled F-actin in control cells
(without any treatment). A similar approach was applied to
quantify the relative expression of P- and E- selectins. A total 300
images were analyzed.
Atomic Force Microscopy
A Bioscope system from Veeco, Inc. equipped with Nanoscope
IVa controller and Nanoscope 5.12 software and mounted on the
top of an Olympus IX81 microscope (Olympus) was used to
perform mechanical and adhesive measurements. All force curves
were processed with the NForceR software (Copyright October
10, 2006; Registration Number TXu1-328-659, Cardiovascular
Research Institute, Texas A&M University System).
Figure 1. Schematic descriptions of membrane tether forma-
tion and biofunctionalization for the AFM cantilever tip.
Membrane tether formation mediated by sLex-selectin bonding during
a monocyte rolling on the endothelial layer (upper) and the strategy
using AFM cantilever tips bio-functionalized by sLex to characterize the
mechanics of membrane tether adhesion (lower). (modified from Yves F.
Dufreˆne, 2008).
doi:10.1371/journal.pone.0060972.g001
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Bio-functionalization of the AFM cantilever tips
We adapted the procedure used by Micic (1999) [16] to
functionalize Si3N4 cantilevers with avidin, followed by incubation
with biotinylated-sLex to further functionalize cantilevers with sLex
coated surface (Fig. 1, lower). Briefly, after a 5-min wash in acetone
followed by UV irradiation for 15 min, triangular silicon nitride
cantilevers (Veeco, Texas) were immersed in 50 ml of biotin-BSA
(Sigma; 0.5 mg/ml in 100 mM NaHCO3) and incubated over-
night in 37uC humid chamber. The biotin-BSA coated cantilevers
were rinsed several times with PBS and fixed in 20% glutaralde-
hyde for 30 min, followed by incubation in the solution containing
avidin (Neutravidin; Pierce, 0.5 mg/ml in 100 mM NaHCO3).
Avidin functionalized cantilevers were washed and then incubated
in the 0.5 mg/ml biotin-sLex solution (Glycotech, Gaithersburg,
MD). At the loading rate ,400 pN/s, the unbinding force of
avidin-biotin is ,200 pN [17], which is much greater than that of
p-selectin-sLex (,50 pN) [12]. Therefore, the biotin-avidin bond
was assumed not to break during our experiments.
Measurements for cell adhesion probability, cell and
membrane stiffness, and force for membrane tether
formation (Fmtf)
The AFM was set to operate in force mode, and the
piezotransducer (PZT) was set to drive the cantilever to approach,
touch, make an indentation of the cell, and retract from the cell
over a predefined distance in the optical axis perpendicular to the
cell surface, which could be identified from the force curve (Fig. 2).
The force curve was generated from the recorded vertical-axis
movement of the PZT and the deflection of the cantilever with a
known dimension (320 mm in length and 22 mm width with a
pyramidal half-angle of 350) and a spring constant of ,1263 pN/
nm measured by the thermal noise method. Fig. 2A shows a
typical force curve with an adhesion event. The sudden release of
force occurred at the rupture of a membrane tether was used as a
measure of Fmtf through the bonding between p-selectin and sLe
x
calculated by multiplying the spring constant of the cantilever with
the deflection height associated with a membrane tether rupture
(Fig. 2A). Since adhesion events sometimes did not occur in some
force curves (Fig. 2B), adhesion probability was calculated by
dividing the number of curves with adhesion events by the total
number of curves. To measure the stiffness of the cell, the part of
the AFM force curve representing cell indentation was fitted by the
Hertz model: F= (2Ed2)/ [p (1-n2) tan a] to calculate E, the
Young’s modulus (i.e. the stiffness) of the cell, where F is the force,
d the indentation, n the Poisson ratio of the cell, assumed to be 0.5,
and a the half-operating angle of the indenting cone. To measure
membrane stiffness, DF/(the depth of indentation) are calculated
within 5 nm indentation at the cell surface (i.e. DF/5 nm). The
loading and unloading speeds of labeled cantilever tips were
1 mm/s, contact time - 0.2 sec. In this study, at least 2000 curves
were analyzed and reported for each experimental group.
Results
Oligomeric Ab1–42 enhanced P-selectin expression at the
CEC surface
To investigate the effects of Ab1–42 oligomers on the expression
of P-selectin at the CEC surface, quantitative immunofluorescence
microscopy (QIM) of P-selectin was performed without cell
permeabilization in the immunostaining procedure. Consistent
with the notion that Ab stimulates CECs for cellular adhesion and
transmigration [18], Ab1–42 increased P-selectin expression at the
surface of bEnd3 cells by 35–60% (Fig. 3B) and primary human
CECs by 10–22% (Fig. 3C). Since histamine is known for its ability
to increase P-selectin at the endothelial surface [15,19,20], results
with histamine were used as a positive control (Fig. 3B). Previous
study also reported the ability of lovastatin to abrogate histamine-
induced increase in P-selectin expression at the endothelial surface
[21]. In this study, lovastatin also suppressed Ab1–42-induced
increase in P-selectin expression at the CEC surface (Fig. 3B).
Ab1–42 enhanced actin polymerization
Ab1–42 has been reported to enhance actin polymerization and
induce actin stress fiber formation in neuronal cells. [22,23]. Since
the organization of cytoskeleton governs cell mechanics and
adhesion, we employed QIM of F-actin labeled with Oregon green
phalloidin to quantify actin polymerization induced by Ab1–42 in
CECs. As shown in Fig. 4A, B and C, QIM data showed that Ab1–
42 and histamine promoted actin polymerization in both primary
human CECs and bEnd3 cells. In contrast, significant reduction of
actin intensity was observed when cells were treated with
latrunculin A, an F-actin disruptive drug (Fig. 4A). Lovastatin
also decreased actin polymerization (Fig. 4B), but unlike
latrunculin, lovastatin did not cause a dramatic disorganization
of the cytoskeleton structure (Fig. 4A).
Figure 2. Typical force curves obtained from AFM measure-
ment. (A) Approach and retraction force curves with adhesion; and (B)
without adhesion. The cantilever approaches (a to b), touches (b),
makes indentation (b to c) and retracts (d) from the cell. Force of
membrane tether formation (Fmtf) was measured at the sudden drop of
force when a rupture of a membrane tether occurred (denoted by an
arrow).
doi:10.1371/journal.pone.0060972.g002
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Adhesion probability and molecular specificity of
adhesion
Consistent with QIM results showing that both histamine and
Ab42 increased P-selectin at the CEC surface (Fig. 3), AFM data
demonstrated that adhesion probability increased upon Ab42 or
histamine treatment (0.3460.07 for control; 0.5160.08 for
histamine; 0.5560.06 and 0.6660.07 for 0.5 mM and 1 mM of
Ab42 respectively), and inhibited after lovastatin treatment
(0.2860.08) (Fig. 5A).
To address whether these adhesion events are specific through
bonding with the selectin-sLex interactions, AFM data demonstrated
Figure 3. Effects of Ab, histamine, and lovastatin on P-selectin
expression at the CEC surface. (A) Fluorescent micrographs of
fluorescently-labeled P-selectin at the bEnd3 cells. (B) Relative P-selectin
intensity at the bEnd3 cell surface and (C) the human primary CEC
surface. ***p#0.001, **p#0.01 compare to the control; uuu p#0.001
compare to the Ab (1 mM) treatment group.
doi:10.1371/journal.pone.0060972.g003
Figure 4. Effects of Ab, and histamine on actin polymerization
in CECs. (A) Fluorescent micrographs of Oregon-green phalloidin-
labeled F-actin in bEnd3 cells. (B) Relative F-actin intensity in bEnd3 cells
and (C) primary human CECs. ***p#0.001, ** p#0.01, * p#0.05 compare
to the control; uuu p#0.001 compare to the Ab (1 mM) treatment group.
doi:10.1371/journal.pone.0060972.g004
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that in cells pretreated with histamine, the probability of adhesion for
cantilevers coated with only biotin was at least twofold lower as
compared to those coated with sLex (Fig. 5B). Lower adhesion
probabilities were also obtained when P-selectin at the cell surface
was blocked with its antibodies (Fig. 5B). These results indicated that
adhesion events and membrane tether formation in this study are
facilitated by specific molecular interactions between p-selectin and
sLex.
Cell stiffness characterized by AFM
The part of the AFM force curves representing cell indentation
was used to measure the stiffness of the cells. As the cantilever tip
of the AFM approached and made a contact at the endothelial
surface (b in Fig. 2A), continued approach makes an indentation (c
in Fig. 2A) at the cell surface. The relationship between the force
applied to make the indentation and the position of the cantilever
was recorded and fitted with Hertz model to calculate the elastic
modulus, which characterized the mechanical stiffness and had a
value 6.861.9 kPa for control CECs (Fig. 6). Both Ab42 and
histamine had a dramatic effect on CECs stiffness, showing
increases to 15.162.7 kPa, 12.262.6 kPa, 19.965.8 kPa for
histamine, 0.5 mM and 1 mM of Ab42, respectively. In contrast,
lovastatin and latrunculin A showed an opposite effect and
significantly decreased stiffness of the cells as compared to the
control (2.360.7 kPa and 2.461.8 kPa for lovastatin and
latrunculin). At the same time, stiffness of the cells was not
significantly changed if lovastatin was applied prior to treatment
with Ab42 (8.461.1 kPa).
Force of membrane tether formation characterized by
AFM
To study the effects of Ab42 oligomers on the force of
membrane tether formation (Fmtf) mediated by sLe
x-selectin
bonding, AFM with cantilever tips bio-functionalized by sLex
were applied (Fig. 1). In the force mode, the piezotransducer (PZT)
was set to drive the cantilever to approach, touch, make an
indentation on the cell, and retract from the cell. As the cantilever
was retracted from the cell, the surface of the cell was lifted up and
formed membrane tethers from the cantilever tip if adhesion
between the cell surface and cantilever tip had occurred [24]. As
the cantilever moved further away from the cell, the rupture of
tether was detected; and the force required to maintain a
membrane tether (i.e. force of membrane tether formation, Fmtf)
was recorded with a fixed retraction speed (1 mm/s). The adhesion
ruptures were detected in the retraction part of force curves as
evident by a sudden change in force acting on the cantilever
(Fig. 2A). Retraction curves without adhesion did not exhibit these
rupture events (Fig. 2B).
Fig. 7 represents the Fmtf measurement for an untreated (control)
and experimental groups of mouse CECs. The average Fmtf was
4465 pN for control CECs. According to the theory of
membrane-cytoskeleton adhesion [25], Ab-induced actin poly-
Figure 5. Effects of Ab, histamine, and lovastatin on adhesion
probability at the bEND3 cell surface with AFM cantilever tips
biofunctionalized by conjugating sLex at their surface. (A)
Adhesion probability was measured for cells treated with histamine, Ab,
lovastatin and Ab and lovastatin alone. Adhesion probability was
calculated by normalizing the number of force curves with adhesion
events by the total number of force curves. ***p#0.001, **p#0.01
compare to the control; uuup#0.001 compare to the Ab (1 mM)
treatment group. (B) bEND3 was treated with histamine, and adhesion
probability was measured. A highest adhesion probability was obtained
for the cantilever coated with sLex; whereas lower adhesion probabil-
ities were obtained for the cantilever coated with biotin only, and cells
treated with antibody of P-selectin, indicating that Fmtf measured in this
study are highly molecularly specific through sLex-P-selectin bonding.
***p#0.001compare to the sLex coating group.
doi:10.1371/journal.pone.0060972.g005
Figure 6. Cell stiffness. (A) Cell stiffness (Elastic modulus) for bEND3
cells treated with histamine, Ab, lovastatin and Ab, lovastatin alone, and
latrunculin A. The elastic modulus was calculated by fitting the cell
indentation part of the force curves with Hertz model. ***p#0.001,
**p#0.01 compare to the control; uup#0.01compare to the Ab (1 mM)
treatment group.
doi:10.1371/journal.pone.0060972.g006
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merization as shown in Fig. 4 may increase membrane-cytoskel-
eton adhesion resulting in a greater Fmtf. Surprisingly, opposite to
results with histamine, Fmtf measured for cells treated with 1 mM
and 0.5 mM Ab was 34% and 18% lower compared with the
control, respectively, (i.e. 2963 pN and 3662 pN for cells treated
with respective 1 mM and 0.5 mM Ab in Fig. 7A). When cells were
treated with latrunculin A, similar results to those with Ab
treatment were obtained. Interestingly, when lovastatin was
applied prior to treatment with Ab, Fmtf was similar to that of
the control (Fig. 7A).
In order to further investigate the effects of Ab on Fmtf,
histograms of Fmtf measured from different experimental groups
(filled bars) were plotted and superimposed with those from the
control group (unfilled bars). This comparison showed that in the
control group, a distribution of Fmtf with a major population peak
at Fmtf<32.5 pN was obtained (Fig. 7B). Histamine enhanced actin
polymerization in cells, and shifted the major population peak to a
higher Fmtf<44 pN, while Latrunculin A disrupted F-actin,
resulting in the peak at a lower Fmtf<22.5 pN (Fig. 7B).
Interestingly, cells treated with 0.5 mM of Ab produced two
population peaks at Fmtf<20 pN and 39 pN (Fig. 7B). The major
population peak corresponding to the lower Fmtf produced by Ab
suggests that Ab caused a disruption of subcellular connectivity
between the plasma membrane and cytoskeleton, since the
distribution at the lower Fmtf was similar to that of cells treated
with Latrunculin A. These mechanical alterations in response to
Ab are dose-dependent, as the peak at the higher Fmtf subsided and
only the major peak at the lower Fmtf remained for cells treated
with a higher dose of Ab (1 mM) (Fig. 7B). Pretreatment of cells
with lovastatin suppressed these mechanical alterations induced by
Ab, as the Fmtf distribution was almost totally overlapped with that
of the control experiment (Fig. 7B).
Characterization of Cell membrane stiffness
The Fmtf data suggests that the treatment of CECs with Ab
caused lower connectivity between plasma membranes and
cytoskeleton. It is believed that higher cytoskeletal connectivity
to membranes should provide additional mechanical strength to
plasma membranes; therefore, cell membrane stiffness can be a
measure for cytoskeletal connectivity to membranes (i.e. the
membrane-cytoskeleton adhesion). To quantify cell membrane
stiffness, we analyzed the ‘‘approaching’’ force curves when the
cantilever made a ,5 nm indentation at the cell surface (Fig. 8B).
5 nm is about the thickness of the bilayer membrane. Consistent
with data of actin polymerization and Fmtf, treatment with
histamine resulted in a higher cell membrane stiffness, while
Latrunculin A resulted in a lower cell membrane stiffness. (Fig. 8A)
On the other hand, Ab caused lower cell membrane stiffness
(Fig. 8A), suggesting that Ab produced lower cytoskeletal
connectivity to plasma membranes in cells. The lower cell
membrane stiffness resulted from Ab was suppressed by lovastatin
(Fig. 8A).
Discussion
Primary capture of circulating monocytes from a bloodstream
mediated by membrane tethering is the initial mechanical step in
transmigration. This dynamic process requires special mechanisms
for establishing stable cell-cell contact. The P- and E-selectins are
the adhesion molecules that specialize in mediating this process on
activated endothelium. P-selectin is stored in Weibel-Palade bodies
inside the endothelial cells and can be mobilized to the cell surface
within minutes [11]. Earlier studies showed upregulation of P-
selectin expression in brain ECs associated with enhanced
transmigration of immune cells across the BBB in pathological
conditions, such as ischemia and atherosclerosis [26,27]. There is
also evidence that Ab soluble aggregates selectively activate
cerebral vascular endothelium and increase transmigration of
monocytes across the BBB [6,7]. Our data here show that Ab42
oligomers promoted the expression of P-selectin at the surface of
the CECs. Since E-selectin induction occurs on the transcriptional
level, the duration of Ab treatment (20 min) did not lead to a
detectable change of E-selectin expression.
In addition to adhesion molecules, such as selectin, the
mechanical properties of the cell membrane are a critical factor
influencing the cell-cell adhesion [13–15]. Earlier works have
confirmed that lower tether extraction force favors rolling. It has
been shown that tether formation reduces the adhesion force
between the endothelial cells and leukocytes, assisting the
formation of new bonds and stabilizing rolling [28]. Enrichment
of endothelial cells with cholesterol has been found to increase
Figure 7. Ab on force of membrane tether formation (Fmtf)
mediated by sLex-selectin bonding. (A) Fmtf was measured at the
sudden drop of force when a rupture of a membrane tether occurred
(Fig. 2A). A bar graph summarizes Fmtf measured for cells treated with
histamine, Ab, lovastatin and latrunculin A. ***p#0.001, **p#0.01,
*p#0.05 compare to the control; uup#0.01 compare to the Ab (1 mM)
treatment group. (B) The distributions of Fmtf were plotted for different
experimental groups. Fmtf distribution for the control group is
represented in unfilled bars, and superimposed with other experimental
groups represented in grey bars for comparison.
doi:10.1371/journal.pone.0060972.g007
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tether length and reduce force bond, and increase the bond
lifetime, which resulted in increased chance of adhesion [14]. We
found that Ab42 oligomers decrease Fmtf and increase probability of
adhesion. Taken together, our data suggest that Ab facilitates
primary capture of monocytes and rolling adhesion at the brain
endothelial cell surface through promoting P-selectin expression,
and lowering Fmtf, which favors adhesion.
Membrane tether extraction strongly depends on the F-actin
network condition and membrane-cytoskeleton integrity [29,30].
It has been shown that disruption of the actin cytoskeleton and
glycocalyx backbone removal lead to decrease of adhesion energy
[31]. Latrunculin A, a well-known inhibitor of actin polymeriza-
tion, has been reported to decrease the cell’s average elastic
modulus and adhesion force [32–34]. It is also observed that
statins can significantly impair F-actin stress fiber formation [35].
Our data are in good agreement with those reported in the
literature showing that latrunculin A and lovastatin lower the
amount of F-actin in the CECs. Consistent with the QIM results,
our AFM study demonstrated that both lovastatin and Latrunculin
A resulted in a decrease of cell stiffness, membrane stiffness, and
Fmtf. Consistent with those from others showing the ability for
histamine to induce cytoskeletal F-actin polymerization and
increase the cell adhesion force [15,36,37], our AFM study also
showed histamine to increase cell stiffening and higher Fmtf.
Although Ab has been found to increase actin polymerization
and cause formation of actin stress fiber [38,39], Ab42 treatment
surprisingly decreased Fmtf mediated by sLe
x-selectin bonding.
Previous studies have demonstrated that variability in tether
extraction force could also provide information in membrane-
cytoskeleton association: enhanced membrane-cytoskeleton inter-
actions make tethers less homogeneous, and, vice versa, no
significant difference is observed in the case of low connectivity
[14]. Our force distribution analysis indicated that in contrast to
histamine, Ab42 (1 mM), significantly decreased force range
variability (Fig. 7B). Therefore, despite that both histamine and
Ab42 enhance P-selectin expression, increase probability of
adhesion, and promote actin polymerization, their effects on Fmtf
are different. Interestingly, two distinct populations of Fmtf were
observed for 0.5 mM Ab42 treatment. The presence of two
populations of Fmtf and a lower cell membrane stiffness indicate
the ability of Ab42 oligomers to weaken locally-subcellular
membrane-cytoskeleton association. Taken together, these me-
chanical results lead to a new hypothesis that Ab induces
dissociation of the adhesion between the cytoskeleton and the
lipid bilayer membrane by disrupting the cytoskeletal linkage to
plasma membranes or altering the attachment of transmembrane
proteins (e.g., cadherins, integrins) to F-actin.
QIM and AFM data have demonstrated that Ab42 oligomers
promoted expression of P- selectin, induced stress fibers formation,
increased cell stiffness but decrease membrane stiffness, increased
the probability of adhesion, and lower Fmtf; and these effects were
suppressed by lovastatin. Statins are the inhibitors of hydroxy-3-
methylglutaryl coenzyme A reductase (HMG-CoA), an enzyme
that catalyzes the cholesterol synthesis in the liver and other tissues
[40]. In addition, statins have been demonstrated to have anti-
inflammatory effects independent of cholesterol reduction. They
attenuate vascular inflammation, upregulate nitric oxide expres-
sion in endothelial cells, microglia and monocytes, inhibit
leukocytes recruitment to vascular cells, and significantly decrease
the migration of monocytes and lymphocytes across the human
BBB [41,42]. Furthermore, statins have been shown to be
potentially therapeutic for AD by inhibiting Ab-stimulated
expression of interleukin-1b and reduce the levels of Ab [43–
45]. A retrospective epidemiological study recently demonstrated
that long-term treatment of hypercholesterolaemic patients with
lovastatin, simvastatin, and pravastatin lowered the risk of
developing AD [43,46–48]. However, the mechanisms linking
Ab and statins on CEC function remain poorly understood. Our
findings showing the effects of Ab42 on the membrane tether
adhesion of cerebral endothelial cells, and how lovastatin
counteracts these effects provide new insights into the mechanism
of neuroinflammation in AD brains, and may offer new
approaches for preventive treatment of the disease. This study
should prove to provide insights into new therapeutic strategies,
since microglial cell activity is a crucial factor in Ab clearance and
immunotherapy for treatment of AD [49,50].
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Figure 8. Membrane stiffness. (A) Membrane stiffness for cells
treated with histamine, Ab, lovastatin and Ab, lovastatin alone, and
latrunculin A. (B) Membrane stiffness is measured by calculating the
slope (denoted by the arrow) from 5 nm indentation at the cell surface.
***p#0.001, **p#0.01 compare to the control; uup#0.01, uuup#0.001
compare to the Ab (1 mM) treatment group.
doi:10.1371/journal.pone.0060972.g008
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